Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Cipla
Argus Health
Citi
Queensland Health
Julphar
Moodys
US Army

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017262

« Back to Dashboard

NDA 017262 describes XENEISOL, which is a drug marketed by Mallinckrodt and is included in one NDA. Additional details are available on the XENEISOL profile page.

The generic ingredient in XENEISOL is xenon xe-133. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the xenon xe-133 profile page.
Summary for 017262
Tradename:XENEISOL
Applicant:Mallinckrodt
Ingredient:xenon xe-133
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INHALATION, INJECTIONStrength18-25mCi/AMP
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Teva
Mallinckrodt
Colorcon
Cipla
Argus Health
Julphar
Boehringer Ingelheim
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.